Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive examination. Supporters often emphasize the opportunity for substantial therapeutic outcomes, particularly in conditions where conventional treatments have proven inadequate. However, this is to consider the significant financial burden associated with CPI stem ce